Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 18;15(14):3665.
doi: 10.3390/cancers15143665.

Image-Guided Ablation Therapies for Extrahepatic Metastases from Hepatocellular Carcinoma: A Review

Affiliations
Review

Image-Guided Ablation Therapies for Extrahepatic Metastases from Hepatocellular Carcinoma: A Review

Noriyuki Umakoshi et al. Cancers (Basel). .

Abstract

The most common sites of extrahepatic metastases from hepatocellular carcinoma (HCC) are the lungs, intra-abdominal lymph nodes, bones, and adrenal glands, in that order. Although systemic therapies are a common treatment for patients with extrahepatic metastases, local ablative therapies for the extrahepatic metastatic lesions can be performed in selected patients. In this article, the literature on image-guided thermal ablation for metastasis to each organ was reviewed to summarize the current evidence. Radiofrequency ablation was the most commonly evaluated technique, and microwave ablation, cryoablation, and percutaneous ethanol injection were also utilized. The local control rate of thermal ablation therapy was relatively favorable, at approximately 70-90% in various organs. The survival outcomes varied among the studies, and several studies reported that the absence of viable intrahepatic lesions was associated with improved survival rates. Since only retrospective data from relatively small studies has been available thus far, more robust studies with prospective designs and larger cohorts are desired to prove the usefulness of thermal ablation for extrahepatic metastases from HCC.

Keywords: ablation therapy; cryoablation; extrahepatic metastases; hepatocellular carcinoma; microwave ablation; percutaneous ethanol injection; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the search strategy.

Similar articles

Cited by

References

    1. Ganne-Carrié N., Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J. Hepatol. 2019;70:284–293. doi: 10.1016/j.jhep.2018.10.008. - DOI - PubMed
    1. Mahmud N., Fricker Z., Hubbard R.A., Ioannou G.N., Lewis J.D., Taddei T.H., Rothstein K.D., Serper M., Goldberg D.S., Kaplan D.E. Risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology. 2021;73:204–218. doi: 10.1002/hep.31558. - DOI - PMC - PubMed
    1. Uka K., Aikata H., Takaki S., Shirakawa H., Jeong S.C., Yamashina K., Hiramatsu A., Kodama H., Takahashi S., Chayama K. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J. Gastroenterol. 2007;13:414–420. doi: 10.3748/wjg.v13.i3.414. - DOI - PMC - PubMed
    1. Yi J., Gwak G.Y., Sinn D.H., Kim Y.J., Kim H.N., Choi M.S., Lee J.H., Koh K.C., Paik S.W., Yoo B.C. Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1. Hepatogastroenterology. 2013;60:328–332. doi: 10.5754/hge12597. - DOI - PubMed
    1. Jin Y.J., Lee H.C., Lee D., Shim J.H., Kim K.M., Lim Y.S., Do K.H., Ryu J.S. Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma. J. Hepatol. 2012;56:1324–1329. doi: 10.1016/j.jhep.2011.12.027. - DOI - PubMed

LinkOut - more resources